Bluebird bio to Be Acquired by Carlyle Group, SK Capital

Dow Jones

Feb 21, 2025

By Colin Kellaher

Bluebird bio has struck a deal to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.

Bluebird on Friday said its investors will receive an initial $3 a share in cash under the deal, along with contingent value rights worth $6.84 a share that would be triggered if the gene-therapy company's current product portfolio achieves $600 million in sales in any trailing 12-month period by the end of 2027.

The potential total value of up to $9.84 a share represents a nearly 40% premium to Thursday's closing price of $7.04 for the Somerville, Mass., company.

The deal is slated to close in the first half of the year.

Trading in shares of bluebird was halted premarket on Friday.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

February 21, 2025 07:59 ET (12:59 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2513670332"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2513670332\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2513670332?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-21 20:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2513670332","market":"sh","top_or_hot":-1,"title":"Bluebird bio to Be Acquired by Carlyle Group, SK Capital","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Bluebird bio has struck a deal to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. \n</p>\n<p>\n  Bluebird on Friday said its investors will receive an initial $3 a share in cash under the deal, along with contingent value rights worth $6.84 a share that would be triggered if the gene-therapy company's current product portfolio achieves $600 million in sales in any trailing 12-month period by the end of 2027. \n</p>\n<p>\n  The potential total value of up to $9.84 a share represents a nearly 40% premium to Thursday's closing price of $7.04 for the Somerville, Mass., company. \n</p>\n<p>\n  The deal is slated to close in the first half of the year. \n</p>\n<p>\n  Trading in shares of bluebird was halted premarket on Friday. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 21, 2025 07:59 ET (12:59 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bluebird bio to Be Acquired by Carlyle Group, SK Capital</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBluebird bio to Be Acquired by Carlyle Group, SK Capital\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-02-21 20:59</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Bluebird bio has struck a deal to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. \n</p>\n<p>\n  Bluebird on Friday said its investors will receive an initial $3 a share in cash under the deal, along with contingent value rights worth $6.84 a share that would be triggered if the gene-therapy company's current product portfolio achieves $600 million in sales in any trailing 12-month period by the end of 2027. \n</p>\n<p>\n  The potential total value of up to $9.84 a share represents a nearly 40% premium to Thursday's closing price of $7.04 for the Somerville, Mass., company. \n</p>\n<p>\n  The deal is slated to close in the first half of the year. \n</p>\n<p>\n  Trading in shares of bluebird was halted premarket on Friday. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  February 21, 2025 07:59 ET (12:59 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4556","symbol_name":"基因编辑","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2513670332","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2513670332","pubTimestamp":1740142740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Bluebird bio has struck a deal to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.Bluebird on Friday said its investors will receive an initial $3 a share in cash under the deal, along with contingent value rights worth $6.84 a share that would be triggered if the gene-therapy company's current product portfolio achieves $600 million in sales in any trailing 12-month period by the end of 2027.The potential total value of up to $9.84 a share represents a nearly 40% premium to Thursday's closing price of $7.04 for the Somerville, Mass., company.The deal is slated to close in the first half of the year.Trading in shares of bluebird was halted premarket on Friday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4556":"基因编辑","BK4578":"CAR-T","BK4139":"生物科技","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","CG":"凯雷","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","BK4135":"资产管理与托管银行","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC"},"translate_title":"蓝鸟生物将被凯雷集团、SK Capital收购","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CG":0.9,"BLUE":1},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Bluebird bio has struck a deal to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million. \n\n\n  Bluebird on Friday said its investors will receive an initial $3 a share in cash under the deal, along with contingent value rights worth $6.84 a share that would be triggered if the gene-therapy company's current product portfolio achieves $600 million in sales in any trailing 12-month period by the end of 2027. \n\n\n  The potential total value of up to $9.84 a share represents a nearly 40% premium to Thursday's closing price of $7.04 for the Somerville, Mass., company. \n\n\n  The deal is slated to close in the first half of the year. \n\n\n  Trading in shares of bluebird was halted premarket on Friday. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 21, 2025 07:59 ET (12:59 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}